Percutaneous mitral balloon valvuloplasty beyond 65 years of age
نویسندگان
چکیده
منابع مشابه
Percutaneous mitral balloon valvuloplasty beyond 65 years of age.
BACKGROUND The profile of subjects undergoing percutaneous mitral balloon valvuloplasty (PMBV) in developed countries has shifted toward the elderly. In the group of elderly patients long-term results after PMBV, as well prognostic factors that may improve patient selection for this procedure have not been fully elucidated. Aim of the study was to evaluate the safety and efficacy of PMBV for th...
متن کاملPercutaneous Balloon Mitral Valvuloplasty
Balloon valvuloplasty techniques and equipment have continued to evolve over the last two decades. With this expanded experience, there has been refinement in patient selection and a clearer understanding of the benefits, limitations, and long-term results of balloon valvuloplasty. In this chapter the mechanisms, indications, techniques and clinical results of balloon valvuloplasty of the mitra...
متن کاملPercutaneous Balloon Mitral Valvuloplasty
Several diseases have been acknowledged as pathological causes for mitral valve stenosis (MS), of which rheumatic heart disease is the most prevalent. Rheumatic heart disease is a chronic manifestation of rheumatic carditis, which occurs in 60% to 90% of cases of rheumatic fever. Rheumatic fever is a late sequela to Group A -hemolytic streptococcal infection of the throat. The initial rheumatic...
متن کاملPercutaneous Balloon Mitral Valvuloplasty
Mitral stenosis (MS) is the most important long-term sequel of rheumatic fever (RF). MS is associated with deterioration of the functional status of the patients and worsens their long-term prognosis. Percutaneous balloon mitral valvuloplasty (BMV) is an effective and safe method in treating rheumatic MS when performed by an experienced operator in a carefully selected patient. A successful BMV...
متن کاملImmediate Results of Percutaneous Mitral Balloon Valvuloplasty in Patients with Mitral Stenosis
Introduction: Mitral stenosis is a prevalent valvular disease in developing countries. Percutaneous mitral balloon valvuloplasty (PMBV) is the gold standard treatment. The main objective of this study was to assess the initial results of PMBV in patients with mitral stenosis during 16 years (2002-2018) in Mashhad, Iran. Materials and Methods: From April 2002 to March 2018, 770 patients underwen...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cardiology Journal
سال: 2013
ISSN: 1898-018X,1897-5593
DOI: 10.5603/cj.2013.0008